Implications of liver injury in risk-stratification and management of patients with COVID-19

Jiaofang Shao(Nanjing Medical University), Ling Lü(Xuzhou Medical College), Xinyi Xia(Nanjing General Hospital of Nanjing Military Command), Bin Huang(Fujian University of Traditional Chinese Medicine), Kening Li(Jiangsu Cancer Hospital), Wenhua You(Nanjing Medical University), Mengyan Zhu(Jiangsu Cancer Hospital), Yuan Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), Tingting Zhang(Peking University), Ziyu Wang(ShanghaiTech University), Wei Wu(Jiangsu Cancer Hospital), Yan Li(Nanjing Medical University), Shukui Wang(Nanjing Medical University), Min Wu(Nanjing Medical University), Rong Ding(Jiangsu Cancer Hospital), Lingxiang Wu(Shanghai Research Center for Acupuncture and Meridians), Qianghu Wang(Nanjing Brain Hospital)
Hepatology International
February 1, 2021
10.1007/s12072-020-10123-0
Cited by 16

Related Papers

COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis
|Journal of Medical Virology|2020|1.6k
Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells
|Cell Reports|2022|465
Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation
|Molecular Cell|2021|265
Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC
|Hepatology|2022|181
β2-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages
|Cancer Research|2022|144